Clincosm LogoSign in Get a demo

Multiple Myeloma

Showing NaN - NaN of 67
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Multiple Myeloma Trial in Worldwide (GMI-1271)

Completed
  • Multiple Myeloma
  • Vejle, Denmark
  • +7 more
Jul 8, 2019

Multiple Myeloma Trial in Worldwide (Carfilzomib, Bortezomib, Dexamethasone)

Completed
Has Results
  • Multiple Myeloma
  • Burbank, California
  • +240 more
Apr 1, 2019

Multiple Myeloma Trial in Australia, China, Korea, Republic of (Thalidomide, Bortezomib, Cyclophosphamide)

Completed
Has Results
  • Multiple Myeloma
  • Adelaide, Australia
  • +22 more
Dec 4, 2018

Multiple Myeloma Trial in Worldwide (pomalidomide, Dexamethasone)

Completed
Has Results
  • Multiple Myeloma
  • Rochester, Minnesota
  • +93 more
Sep 25, 2018

Multiple Myeloma Trial in Worldwide (ABBV-838, Pomalidomide, Dexamethasone)

Terminated
  • Multiple Myeloma
  • Chicago, Illinois
  • +18 more
Sep 12, 2018

Multiple Myeloma Trial in Germany (Auto-Allo Tandem SCT and maintenance therapy with Thalidomide/ DLI, auto-auto Tandem stem

Unknown status
  • Multiple Myeloma
  • Auto-Allo Tandem SCT and maintenance therapy with Thalidomide/ DLI
  • auto-auto Tandem stem cell transplantation and maintenance therapy with Thalidomide
  • Augsburg, Germany
  • +19 more
May 3, 2018

Multiple Myeloma Trial in Germany (Lenalidomide)

Completed
  • Multiple Myeloma
  • Heidelberg, Baden-Württemberg, Germany
  • +4 more
Jan 17, 2018

Multiple Myeloma Trial in Worldwide (CC-5013 plus dexamethasone, Dexamethasone plus Placebo)

Completed
Has Results
  • Multiple Myeloma
  • CC-5013 plus dexamethasone
  • Dexamethasone plus Placebo
  • Camperdown, New South Wales, Australia
  • +68 more
Sep 18, 2017

Multiple Myeloma Trial in Worldwide (bortezomib (optimized retreatment), dexamethasone (optimized retreatment), bortezomib

Completed
  • Multiple Myeloma
  • bortezomib (optimized retreatment)
  • +3 more
  • Antwerpen, Belgium
  • +53 more
Feb 16, 2017

Multiple Myeloma Trial in Hamburg, Heidelberg (Revlimid (Lenalidomide))

Completed
  • Multiple Myeloma
  • Revlimid (Lenalidomide)
  • Hamburg, Germany
  • +1 more
May 12, 2015

Multiple Myeloma Trial in Czech Republic, Germany, United States (Bortezomib, Dexamethasone, PD 0332991)

Completed
Has Results
  • Multiple Myeloma
  • Chicago, Illinois
  • +18 more
Mar 4, 2015

Multiple Myeloma Trial in Heidelberg (POL6326)

Completed
  • Multiple Myeloma
  • Heidelberg, Germany
    Department of Internal Medicine V
Apr 22, 2014

Multiple Myeloma Trial in Canada, Germany, United States (Granulocyte colony-stimulating factor plus plerixafor, Granulocyte

Completed
Has Results
  • Multiple Myeloma
  • Granulocyte colony-stimulating factor plus plerixafor
  • Granulocyte colony-stimulating factor plus placebo
  • Phoenix, Arizona
  • +38 more
Feb 10, 2014

Lymphoma, Non-Hodgkin, Multiple Myeloma Trial in Cologne, Dresden, Heidelberg (G-CSF Plus Plerixafor)

Completed
Has Results
  • Lymphoma, Non-Hodgkin
  • Multiple Myeloma
  • G-CSF Plus Plerixafor
  • Cologne, Germany
  • +2 more
Feb 10, 2014

Multiple Myeloma Trial in Worldwide (Placebo, Velcade and dexamethasone, Siltuximab, Velcade and dexamethasone)

Withdrawn
  • Multiple Myeloma
  • Placebo, Velcade and dexamethasone
  • Siltuximab, Velcade and dexamethasone
  • Iowa City, Iowa
  • +48 more
Jan 25, 2013

Multiple Myeloma Trial in Worldwide (bortezomib)

Completed
  • Multiple Myeloma
  • Berkeley, California
  • +92 more
Jan 12, 2012

Multiple Myeloma Trial in Worldwide (bortezomib)

Completed
  • Multiple Myeloma
  • Little Rock, Arkansas
  • +75 more
Jan 12, 2012